Polaryx Therapeutics PLYX Income Statement (2024-2026)

NASDAQ PLYX

$2.14 -0.02 (-0.93%)

At close: Aug 20, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2024	Mar2025	Dec2025	Mar2026	Jun2026
Operating items
Research & Development (Quarter)		4.72M		0.68M	0.72M
Selling, General & Administrative (Quarter)		0.34M		1.28M	0.66M
Operating Expenses (Quarter)		5.05M		1.96M	1.38M
Operating Income (Quarter)		-5.05M		-1.96M	-1.38M
EBIT (Quarter)		-5.05M		-1.96M	-1.38M
Net income details
EBT (Quarter)		-5.05M		-1.96M	-1.38M
Profit After Tax (Quarter)		-5.05M		-2.54M	-1.40M
Income from Continuing Operations (Quarter)		-5.05M		-1.96M	-1.38M
Consolidated Net Income (Quarter)		-5.05M		-1.96M	-1.38M
Income towards Parent Company (Quarter)		-5.05M		-1.96M	-1.38M
Net Income towards Common Stockholders (Quarter)		-5.05M		-2.54M	-1.38M
Additional items
EPS (Basic) (Quarter)		-0.11		-0.05	-0.03
EPS (Diluted) (Quarter)		-0.11		-0.05	-0.03
Shares Outstanding (Quarter)	34.20M	44.34M	45.42M	47.22M	48.28M
Shares Outstanding (Diluted) (Quarter)	34.20M	44.34M	45.42M	47.22M	48.28M
Shares Outstanding (Entity) (Quarter)	34.20M	45.07M	47.34M	47.34M	49.85M
EBITDA (Quarter)		-5.05M		-1.96M	-1.38M
Interest Expenses (Quarter)	4.87M		6.39M